Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow
Ekso Bionics (NASDAQ:EKSO), a leader in medical and industrial exoskeleton technology, has scheduled its Q2 2025 financial results release for July 28, 2025 after market close. The company will host a conference call at 1:30 PM PT / 4:30 PM ET to discuss financial performance and recent business developments.
Investors can join via phone by dialing 877-407-6184 (domestic) or 201-389-0877 (international). The presentation will also be available through a live webcast and archived on the company's investor relations website.
Ekso Bionics (NASDAQ:EKSO), leader nella tecnologia di esoscheletri medici e industriali, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per il 28 luglio 2025 dopo la chiusura del mercato. La società terrà una conference call alle 13:30 PT / 16:30 ET per discutere delle performance finanziarie e degli ultimi sviluppi aziendali.
Gli investitori potranno partecipare telefonicamente chiamando il 877-407-6184 (nazionale) o il 201-389-0877 (internazionale). La presentazione sarà inoltre disponibile tramite webcast in diretta e archiviata sul sito web delle relazioni con gli investitori della società.
Ekso Bionics (NASDAQ:EKSO), líder en tecnología de exoesqueletos médicos e industriales, ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el 28 de julio de 2025 después del cierre del mercado. La compañía realizará una llamada conferencia a las 1:30 PM PT / 4:30 PM ET para discutir el desempeño financiero y los desarrollos recientes del negocio.
Los inversionistas pueden unirse por teléfono marcando 877-407-6184 (nacional) o 201-389-0877 (internacional). La presentación también estará disponible mediante una transmisión en vivo y archivada en el sitio web de relaciones con inversionistas de la compañía.
Ekso Bionics (NASDAQ:EKSO)는 의료 및 산업용 외골격 기술 분야의 선두주자로서 2025년 2분기 재무실적을 2025년 7월 28일 장 마감 후 발표할 예정입니다. 회사는 재무 성과 및 최근 사업 동향에 대해 논의하기 위해 오후 1:30 PT / 오후 4:30 ET에 컨퍼런스 콜을 개최합니다.
투자자들은 국내 전화 877-407-6184 또는 국제 전화 201-389-0877로 참여할 수 있습니다. 발표는 라이브 웹캐스트로도 제공되며 회사 투자자 관계 웹사이트에 아카이브됩니다.
Ekso Bionics (NASDAQ:EKSO), leader dans la technologie des exosquelettes médicaux et industriels, a prévu la publication de ses résultats financiers du deuxième trimestre 2025 pour le 28 juillet 2025 après la clôture du marché. La société organisera une conférence téléphonique à 13h30 PT / 16h30 ET pour discuter des performances financières et des développements récents de l'entreprise.
Les investisseurs peuvent participer par téléphone en composant le 877-407-6184 (national) ou le 201-389-0877 (international). La présentation sera également disponible via un webinaire en direct et archivée sur le site des relations investisseurs de la société.
Ekso Bionics (NASDAQ:EKSO), ein führendes Unternehmen im Bereich medizinischer und industrieller Exoskelett-Technologie, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 28. Juli 2025 nach Börsenschluss geplant. Das Unternehmen wird um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz abhalten, um die finanzielle Leistung und aktuelle Geschäftsentwicklungen zu besprechen.
Investoren können telefonisch unter 877-407-6184 (national) oder 201-389-0877 (international) teilnehmen. Die Präsentation wird auch per Live-Webcast verfügbar sein und auf der Investor-Relations-Website des Unternehmens archiviert.
- None.
- None.
SAN RAFAEL, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter of 2025 after the close of trading on Monday, July 28, 2025. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to review the financial results and discuss recent business developments.
To participate in the conference call by telephone, please dial 877-407-6184 (domestic) or 201-389-0877 (international). The call will also be broadcast live and archived on the Company’s website at www.eksobionics.com under “Presentations & Events” in the Investors section.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Based upon its industry-leading expertise, the Company focuses on improving health and quality of life with advanced robotics designed to enhance, amplify, and restore human function. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com.
Contact:
Stephen Kilmer
Investor Relations
Direct: (646) 274-3580
Email: skilmer@eksobionics.com
FAQ
When will Ekso Bionics (EKSO) release Q2 2025 earnings?
What time is the Ekso Bionics Q2 2025 earnings call?
How can I listen to Ekso Bionics (EKSO) Q2 2025 earnings call?
Where can I find the replay of Ekso Bionics Q2 2025 earnings call?
